PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,909,256 | $41,564,265 | 0.82% |
| Boxer Capital, LLC | 2,568,287 | $9,785,173 | 0.52% |
| Baker Brothers Advisors | 10,123,824 | $38,571,769 | 0.49% |
| Sio Capital Management, LLC | 320,394 | $1,220,701 | 0.33% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,133,000 | $15,746,730 | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 123,600 | $470,916 | 0.01% |
| EXCHANGE TRADED CONCEPTS, LLC | 48,727 | $185,650 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 18,839 | $71,777 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11,074 | $42,192 | 0.00% |
| KENNEDY CAPITAL MANAGEMENT LLC | 35,283 | $134,428 | 0.00% |